Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Nanoscope Therapeutics Appoints Industry Veteran Vicente Anido Jr., Ph.D., as a Strategic Advisor
Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]
Cambrian Bio Appoints Health Policy Veteran Adrienne Hallett as Vice President of Global Policy and Strategic Initiatives
Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, […]
Azafaros Appoints Chief Operating Officer and Head of Finance
Azafaros today announced two appointments to their executive management team with Silvia Ragno, PhD, joining […]
GeminiBio Appoints Industry Veteran Cory Stevenson as Executive Chairman
Gemini BioProducts (GeminiBio), a portfolio company of BelHealth Investment Partners, a Florida-based healthcare private equity […]
Vanda Pharmaceuticals Appoints Dr. Tage Honoré to its Board of Directors
Vanda Pharmaceuticals today announced the appointment of Dr Tage Honoré, Ph.D., D.Sc. to its Board […]
Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology
Invitae, a leading medical genetics company, has announced the appointment of Dr. W. Michael Korn, […]
Sage Therapeutics Appoints Jessica Federer to Board of Directors
Sage Therapeutics, a biopharmaceutical company leading the way to create a world with better brain […]
DEM BioPharma Appoints Miriam Merad, M.D., Ph.D., to Scientific Advisory Board
DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and macrophages […]
Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth
Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral […]
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
Diamyd Medical today announced that Karin Rosén will join the Board of Directors as an […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more